| scholarly article | Q13442814 |
| P2093 | author name string | Qing Ye | |
| Tian Liu | |||
| Jin Sun | |||
| Zhonggui He | |||
| Xiao Tan | |||
| Dun Wang | |||
| Zhaomeng Wang | |||
| Mengchi Sun | |||
| Zisen Gao | |||
| Yanxian Hou | |||
| P2860 | cites work | Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract | Q34190317 |
| Rod shaped nanocrystals exhibit superior in vitro dissolution and in vivo bioavailability over spherical like nanocrystals: a case study of lovastatin | Q35576407 | ||
| Solid state characterization of azelnidipine-oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs | Q36290858 | ||
| Effective management of hypertension with dihydropyridine calcium channel blocker-based combination therapy in patients at high cardiovascular risk | Q36572955 | ||
| Pharmaceutical excipients - quality, regulatory and biopharmaceutical considerations | Q38677702 | ||
| Recent advances in co-amorphous drug formulations | Q38710042 | ||
| Influence of variation in molar ratio on co-amorphous drug-amino acid systems | Q39638481 | ||
| Formation Mechanism of Coamorphous Drug-Amino Acid Mixtures. | Q40854029 | ||
| Mechanism-based selection of stabilization strategy for amorphous formulations: Insights into crystallization pathways | Q41016139 | ||
| Supersaturating drug delivery systems: The potential of co-amorphous drug formulations. | Q47718326 | ||
| Viewing Molecular and Interface Interactions of Curcumin Amorphous Solid Dispersions for Comprehending Dissolution Mechanisms. | Q47783687 | ||
| Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance | Q47810974 | ||
| Probing Pharmaceutical Mixtures during Milling: The Potency of Low-Frequency Raman Spectroscopy in Identifying Disorder. | Q47865775 | ||
| Facile formation of co-amorphous atenolol and hydrochlorothiazide mixtures via cryogenic-milling: Enhanced physical stability, dissolution and pharmacokinetic profile | Q47891325 | ||
| Experimental observations and dissipative particle dynamic simulations on microstructures of pH-sensitive polymer containing amorphous solid dispersions | Q48921407 | ||
| Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability | Q49496136 | ||
| Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions. | Q50881261 | ||
| Solid-state flurbiprofen and methyl-β-cyclodextrin inclusion complexes prepared using a single-step, organic solvent-free supercritical fluid process. | Q51338534 | ||
| Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs. | Q51379052 | ||
| Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen. | Q51542358 | ||
| Physical Stability and Dissolution Behavior of Ketoconazole-Organic Acid Coamorphous Systems. | Q53436393 | ||
| Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect. | Q55248249 | ||
| Predicting final product properties of melt extruded solid dispersions from process parameters using Raman spectrometry | Q57162915 | ||
| Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions | Q59234583 | ||
| Clinical Position of Lacidipine, a New Dihydropyridine Calcium Antagonist, in the Treatment of Hypertension | Q67712776 | ||
| Calcium channel antagonist effects of spironolactone, an aldosterone antagonist | Q68463591 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 95-103 | |
| P577 | publication date | 2018-11-14 | |
| P1433 | published in | Asian Journal of Pharmaceutical Sciences | Q50552622 |
| P1476 | title | Co-amorphous solid dispersion systems of lacidipine-spironolactone with improved dissolution rate and enhanced physical stability | |
| P478 | volume | 14 |
Search more.